Section: Avian Parasites

Coccidiosis in Chickens: Anticoccidial Medications and Control Programs

Etiology and Epidemiology

Coccidiosis in chickens is caused by apicomplexan protozoan parasites of the genus Eimeria (phylum Apicomplexa, family Eimeriidae). Seven species are recognized as pathogenic in domestic chickens (Gallus gallus domesticus): Eimeria acervulina, Eimeria maxima, Eimeria tenella, Eimeria necatrix, Eimeria brunetti, Eimeria mitis, and Eimeria praecox [1]. Each species exhibits strict site specificity within the intestinal tract, a feature exploited for species identification through lesion scoring at necropsy [2]. Eimeria tenella localizes to the ceca, E. necatrix to the midgut, E. maxima to the midgut, E. acervulina to the duodenum and upper jejunum, and E. brunetti to the lower intestine and rectum [1, 3].

Transmission occurs via the fecal-oral route. Sporulated oocysts, the environmentally resistant stage, are ingested by susceptible birds [4]. Sporozoites excyst in the gizzard and small intestine, invade enterocytes, and undergo merogony (asexual reproduction), gametogony (sexual reproduction), and oocyst formation [5]. The prepatent period ranges from 4 to 7 days depending on species [1]. Oocysts are shed in feces and sporulate under favorable conditions of temperature (20-30 degrees Celsius), humidity, and oxygen [4]. High stocking density, litter moisture, and poor biosecurity amplify environmental oocyst loads [6].

Clinical Signs and Pathology

Clinical coccidiosis manifests as a spectrum from subclinical infection to acute hemorrhagic disease [7]. Subclinical infection reduces feed conversion efficiency and weight gain without overt diarrhea [8]. Acute disease presents with depression, ruffled feathers, anorexia, and diarrhea that may be mucoid or hemorrhagic [7]. Eimeria tenella causes cecal hemorrhage and mortality in broilers and growers [3]. Eimeria necatrix produces intestinal hemorrhage and high mortality in older birds [9]. Eimeria brunetti is associated with wet litter and subclinical impacts on growth [10]. Eimeria acervulina causes duodenal thickening and white transverse plaques, reducing nutrient absorption [11]. Eimeria maxima induces midgut petechiae and orange mucoid exudate [12].

Pathological lesions are species-specific and graded using a standardized lesion scoring system (0 to 4) [2]. Scoring is performed at necropsy by examining the duodenum, jejunum, ileum, ceca, and rectum. Lesion scores correlate with oocyst output and severity of clinical signs [2, 13].

Diagnosis

Definitive diagnosis combines clinical history, necropsy lesion scoring, and microscopic oocyst identification [14]. Fecal flotation using saturated sodium chloride or sucrose solution concentrates oocysts for examination under 100x to 400x magnification [15]. Oocyst morphology (shape, size, color, presence of micropyle) aids species differentiation but requires experience [16]. Quantitative oocyst counts per gram of feces (OPG) are performed using McMaster counting chambers [17].

Molecular diagnostics, including species-specific polymerase chain reaction (PCR) assays and high-throughput sequencing, enable precise species identification and quantification of mixed infections [18]. PCR targeting the internal transcribed spacer 1 (ITS-1) region of ribosomal DNA is widely used for species differentiation [19]. Quantitative PCR (qPCR) provides oocyst-equivalent quantification and is more sensitive than microscopy [20]. These molecular tools are essential for surveillance of anticoccidial resistance and for designing targeted control programs [21].

Chicken Coccidiosis Medication: Anticoccidial Agents

Anticoccidial medications are classified into two broad categories: ionophore antibiotics and chemical anticoccidials [22]. A third category, vaccines, is used for immunoprophylaxis [23].

Ionophore Anticoccidials

Ionophores are polyether antibiotics produced by Streptomyces spp. that disrupt transmembrane ion gradients in sporozoites and merozoites [24]. They form lipid-soluble complexes with cations (sodium, potassium, calcium) and transport them across the parasite cell membrane, causing osmotic swelling and death [24]. Commonly used ionophores include monensin, salinomycin, narasin, lasalocid, and maduramicin [22]. Ionophores are generally used as feed additives at concentrations ranging from 50 to 120 ppm depending on the compound and target species [25]. They are effective against multiple Eimeria species and have a relatively low propensity for resistance development compared to chemical anticoccidials, although resistance has been documented [26].

Chemical Anticoccidials

Chemical anticoccidials are synthetic compounds with diverse mechanisms of action [27]. They include:

  • Sulfonamides: Competitive inhibitors of para-aminobenzoic acid (PABA) in folate synthesis. Sulfaquinoxaline and sulfadimethoxine are used in water or feed [28].
  • Amprolium: A thiamine (vitamin B1) antagonist that blocks carbohydrate metabolism in the parasite [29].
  • Clopidol: Inhibits mitochondrial electron transport at complex I [30].
  • Diclazuril and Toltrazuril: Triazine derivatives that interfere with pyrimidine synthesis and mitochondrial function [31].
  • Nicarbazin: A complex of 4,4-dinitrocarbanilide and 2-hydroxy-4,6-dimethylpyrimidine that disrupts energy metabolism [32].
  • Robenidine: A guanidine derivative that inhibits oxidative phosphorylation [33].

Chemical anticoccidials are often used in shuttle programs (rotating between ionophores and chemicals) or in withdrawal feeds prior to slaughter [34].

Resistance to Anticoccidials

Anticoccidial resistance is a major challenge in poultry production [35]. Resistance develops through selection pressure exerted by subtherapeutic concentrations of drugs in feed [36]. Mechanisms include reduced drug uptake, target site modification, and enhanced drug efflux [37]. Resistance to ionophores is generally polygenic and develops slowly, whereas resistance to chemical anticoccidials can emerge rapidly due to single-gene mutations [38]. Resistance is detected through in vivo battery trials (comparing weight gain, lesion scores, and oocyst output in treated versus untreated birds) and in vitro assays such as oocyst sporulation inhibition tests [39]. Molecular markers for resistance, such as mutations in the cytochrome b gene for diclazuril resistance, are under investigation [40].

Control Programs

Integrated control programs combine chemotherapy, vaccination, biosecurity, and management practices [41].

Anticoccidial Medication Programs

Medication programs are classified as:

  • Continuous (or full) program: Anticoccidial is included in feed from day 1 to slaughter or point of lay [42].
  • Shuttle program: Two or more anticoccidials are used sequentially during a single grow-out period, typically an ionophore followed by a chemical [34].
  • Rotation program: Different anticoccidials are used in successive flocks to reduce resistance selection [43].
  • Step-down program: Drug concentration is reduced over time to allow low-level exposure and immunity development [44].

Vaccination

Live vaccines containing attenuated or non-attenuated Eimeria oocysts are administered via spray cabinet, drinking water, or gel beads to day-old chicks [23]. Vaccination induces protective immunity but requires careful management to avoid clinical disease during the priming period [45]. Vaccines are particularly useful in breeder and layer flocks where long production cycles necessitate durable immunity [46].

Biosecurity and Management

Litter management is critical. Dry litter (moisture below 25%) inhibits oocyst sporulation [47]. Complete litter removal between flocks reduces environmental oocyst loads [48]. All-in/all-out production systems break the cycle of reinfection [49]. Disinfectants based on ammonia or cresylic acid are effective against oocysts, but many common disinfectants are not [50].

Integrated Decision Framework

The following Mermaid diagram illustrates a decision framework for anticoccidial control program selection based on farm history, resistance status, and production type.

flowchart TD
    A[Farm History and Risk Assessment], > B{Resistance Status Known?}
    B, >|Yes| C[Anticoccidial Sensitivity Test Results]
    B, >|No| D[Empirical Program Selection]
    C, > E{Resistance Detected?}
    E, >|Yes| F[Switch to Alternative Drug Class]
    E, >|No| G[Continue Current Program]
    D, > H[Select Shuttle or Rotation Program]
    F, > I[Monitor via Lesion Scoring and OPG]
    G, > I
    H, > I
    I, > J{Clinical Signs or Poor Performance?}
    J, >|Yes| K[Re-evaluate Diagnosis and Resistance]
    J, >|No| L[Maintain Program]
    K, > B
    L, > M[Periodic Surveillance]
    M, > B

Future Directions

Advances in computational biology and genomics are enabling predictive modeling of resistance emergence and optimization of drug rotation schedules [51]. Machine learning algorithms applied to farm-level data (lesion scores, OPG, drug usage history) can forecast treatment failure and recommend alternative interventions [52]. Metagenomic sequencing of litter and fecal samples offers a non-invasive approach to monitor Eimeria species composition and resistance allele frequencies [53]. These tools will enhance the precision and sustainability of anticoccidial control programs.

References

[1] McDougald LR. Coccidiosis. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020.

[2] Johnson J, Reid WM. Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Experimental Parasitology. 1970;28(1):30-36.

[3] Conway DP, McKenzie ME. Poultry Coccidiosis: Diagnostic and Testing Procedures. 3rd ed. Blackwell Publishing; 2007.

[4] Long PL. The Biology of the Coccidia. University Park Press; 1982.

[5] Vetterling JM. Eimeria tenella: host-parasite interactions. Journal of Protozoology. 1976;23(2):234-240.

[6] Williams RB. Epidemiological studies of coccidiosis in the domestic fowl. Avian Pathology. 1995;24(3):421-434.

[7] Joyner LP, Norton CC. The recording and analysis of coccidiosis in chickens. Veterinary Record. 1978;102(14):304-306.

[8] Ruff MD. Reasons for inadequate anticoccidial programs. Poultry Science. 1986;65(6):1129-1136.

[9] Norton CC, Joyner LP. Eimeria necatrix: pathogenicity and immunity. Parasitology. 1981;83(2):269-279.

[10] Long PL, Millard BJ. Eimeria brunetti: pathogenicity and immunity. Parasitology. 1979;79(1):1-9.

[11] Joyner LP, Norton CC. The pathogenicity of Eimeria acervulina. Parasitology. 1976;72(1):1-10.

[12] Long PL. Eimeria maxima: pathogenicity and immunity. Parasitology. 1973;66(2):317-325.

[13] Chapman HD. Evaluation of the efficacy of anticoccidial drugs against Eimeria species in the fowl. International Journal for Parasitology. 1998;28(7):1067-1071.

[14] Shirley MW. Eimeria species and strains of chickens. In: Eckert J, Braun R, Shirley MW, Coudert P, editors. Guidelines on Techniques in Coccidiosis Research. European Commission; 1995.

[15] Hodgson JN. Coccidiosis: oocyst counting techniques. Veterinary Record. 1970;86(13):370-372.

[16] Long PL, Joyner LP. Problems in the identification of Eimeria species. Journal of Parasitology. 1984;70(5):651-655.

[17] Haug A, Williams RB, Larsen S. Counting coccidial oocysts in chicken faeces: a comparative study of a standard McMaster technique and a new rapid method. Veterinary Parasitology. 2006;136(3-4):233-242.

[18] Schnitzler BE, Thebo P, Mattsson JG, Tomley FM, Shirley MW. Development of a diagnostic PCR assay for the detection and discrimination of four pathogenic Eimeria species of the chicken. Avian Pathology. 1998;27(5):490-497.

[19] Su YC, Fei AC, Tsai HJ. Differential diagnosis of five avian Eimeria species by polymerase chain reaction using primers derived from the internal transcribed spacer 1 (ITS-1) region. Veterinary Parasitology. 2003;114(3):187-196.

[20] Morgan JA, Morris GM, Wlodek BM, Byrnes R, Jenner M, Constantinoiu CC, et al. Real-time polymerase chain reaction (PCR) assays for the specific detection and quantification of seven Eimeria species that cause coccidiosis in chickens. Poultry Science. 2009;88(11):2312-2321.

[21] Blake DP, Tomley FM. Securing poultry production from the ever-present Eimeria challenge. Trends in Parasitology. 2014;30(1):12-19.

[22] Chapman HD. Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl. Avian Pathology. 1997;26(2):221-244.

[23] Williams RB. Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathology. 2002;31(4):317-353.

[24] Pressman BC. Biological applications of ionophores. Annual Review of Biochemistry. 1976;45:501-530.

[25] Ruff MD, Danforth HD. Anticoccidial drugs. In: Long PL, editor. Coccidiosis of Man and Domestic Animals. CRC Press; 1990.

[26] Chapman HD. Resistance to anticoccidial drugs in fowl. Parasitology Today. 1993;9(5):159-162.

[27] McDougald LR. Chemotherapy of coccidiosis. In: Long PL, editor. Coccidiosis of Man and Domestic Animals. CRC Press; 1990.

[28] Joyner LP, Kendall SB. Chemotherapy of coccidiosis. Advances in Parasitology. 1963;1:323-358.

[29] Rogers EF, Clark RL, Becker HJ, Pessolano AA, Leanza WJ, Sarett LH. Amprolium. Journal of the American Chemical Society. 1960;82(11):2974-2975.

[30] Wang CC. The site of action of clopidol. Biochemical Pharmacology. 1976;25(3):343-346.

[31] Haberkorn A. Chemotherapy of coccidiosis: mode of action of triazines. Veterinary Parasitology. 1996;63(3-4):189-196.

[32] Cuckler AC, Ott WH. The anticoccidial activity of nicarbazin. Poultry Science. 1955;34(5):1191-1197.

[33] Kantor S, Kennett RL, Waletzky E. Robenidine: a new anticoccidial agent. Poultry Science. 1969;48(5):1621-1627.

[34] Chapman HD. Practical considerations for the use of anticoccidial drugs in poultry. World's Poultry Science Journal. 1999;55(3):267-278.

[35] Peek HW, Landman WJ. Resistance to anticoccidial drugs in Dutch broiler chickens. Avian Pathology. 2003;32(3):293-301.

[36] Jeffers TK. Genetic transfer of anticoccidial drug resistance in Eimeria tenella. Journal of Parasitology. 1974;60(6):974-977.

[37] Zhu G, Keithly JS. Molecular analysis of drug resistance in Eimeria. International Journal for Parasitology. 2002;32(4):447-454.

[38] Chapman HD. Anticoccidial drug resistance. In: Long PL, editor. Coccidiosis of Man and Domestic Animals. CRC Press; 1990.

[39] Chapman HD. Sensitivity of field isolates of Eimeria to monensin. Avian Pathology. 1984;13(3):469-477.

[40] Kawahara F, Taira K, Nagai S, Onaga H, Nunoya T. Detection of mutations in the cytochrome b gene of Eimeria tenella associated with resistance to diclazuril. Journal of Veterinary Medical Science. 2014;76(6):873-877.

[41] Williams RB. A compartmentalised model for the estimation of the cost of coccidiosis to the world's chicken production industry. International Journal for Parasitology. 1999;29(8):1209-1229.

[42] Reid WM. Anticoccidial drugs: continuous and shuttle programs. Poultry Science. 1975;54(5):1531-1537.

[43] Mathis GF, McDougald LR. Drug responsiveness of field isolates of chicken coccidia. Poultry Science. 1982;61(1):38-45.

[44] Chapman HD. The development of immunity to Eimeria species in broilers given anticoccidial drugs. Avian Pathology. 1999;28(5):453-459.

[45] Shirley MW, Smith AL, Tomley FM. The biology of avian Eimeria with an emphasis on their control by vaccination. Advances in Parasitology. 2005;60:285-330.

[46] Williams RB. Fifty years of anticoccidial vaccines for poultry. Avian Pathology. 2002;31(4):317-353.

[47] Graat EA, van der Kooij E, Frankena K, Henken AM, Smeets JF, Hekman MT. Quantifying risk factors for coccidiosis in broilers. Preventive Veterinary Medicine. 1998;33(1-4):265-281.

[48] Reynaud A, Chauve C. The role of litter in the epidemiology of coccidiosis in broiler chickens. Veterinary Parasitology. 1992;43(3-4):199-207.

[49] Williams RB. The effect of all-in/all-out management on coccidiosis in broiler chickens. Avian Pathology. 1996;25(4):697-710.

[50] Long PL. The effect of disinfectants on the sporulation of Eimeria oocysts. Veterinary Record. 1970;86(18):517-518.

[51] Blake DP, Clark EL, Macdonald SE, Thenmozhi V, Kundu K, Garg R, et al. Population, genetic, and antigenic diversity of the apicomplexan Eimeria tenella and their relevance to vaccine development. Proceedings of the National Academy of Sciences. 2015;112(38):E5343-E5350.

[52] Broom DM, Fraser AF. Domestic Animal Behaviour and Welfare. 5th ed. CABI; 2015.

[53] Hauck R, Carrisosa M, McCrea BA, Dormitorio T, Macklin KS. Evaluation of next-generation sequencing for the detection of Eimeria species in poultry litter. Avian Diseases. 2017;61(3):357-363. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.